Cesca Therapeutics is a regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. The Company’s device division, ThermoGenesis Corp., provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Cesca’s clinical development division is leveraging its proprietary AutoXpress technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopedic markets.

Employee Rating

2.5More
TypePublic
HQRancho Cordova, US
Founded1986
Size (employees)95 (est)
Websitecescatherapeutics.com
Cesca Therapeutics was founded in 1986 and is headquartered in Rancho Cordova, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Cesca Therapeutics Office Locations

Cesca Therapeutics has offices in Rancho Cordova, Gurgaon and Wuxi Shi
Rancho Cordova, (HQ)
2711 Citrus Rd
Gurgaon, (HQ)
857 Udyog Vihar Phase V
Wuxi Shi,
800 Jie Fang Dong Lu
Show all (3)
Report incorrect company information

Cesca Therapeutics Financials and Metrics

Cesca Therapeutics Revenue

Embed Graph
View revenue for all periods
Cesca Therapeutics's revenue was reported to be $14.53 m in FY, 2017
USD

Revenue (Q2, 2018)

2.0m

Gross profit (Q2, 2018)

363.0k

Gross profit margin (Q2, 2018), %

18.1%

Net income (Q2, 2018)

(27.2m)

EBIT (Q2, 2018)

(30.5m)

Market capitalization (30-Nov-2018)

7.0m

Closing stock price (30-Nov-2018)

0.3

Cash (30-Jun-2018)

3.1m
Cesca Therapeutics's current market capitalization is $7 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

16.0m16.0m11.9m14.5m

Revenue growth, %

0%(26%)

Cost of goods sold

10.1m11.3m9.2m8.7m

Gross profit

5.9m4.7m2.7m5.8m
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q1, 2018Q2, 2018

Revenue

4.0m3.7m4.6m4.0m2.8m3.3m2.8m3.8m4.0m3.3m3.1m1.9m2.0m

Cost of goods sold

2.5m2.5m3.1m2.9m2.5m2.3m2.4m2.4m2.5m1.9m9.9m1.5m1.6m

Gross profit

1.5m1.2m1.5m1.1m367.0k1.0m408.0k1.4m1.6m1.4m(6.8m)352.0k363.0k

Gross profit Margin, %

38%32%33%28%13%31%14%37%39%42%(221%)19%18%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

14.8m3.4m5.8m3.5m

Accounts Receivable

6.2k

Inventories

5.6m4.6m

Current Assets

25.3m13.3m12.8m11.5m
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q1, 2018Q2, 2018

Cash

6.6m10.7m8.4m4.8m6.6m2.9m7.2m5.6m4.9m3.8m2.5m2.9m3.1m

Accounts Receivable

258.0k

Inventories

4.8m5.9m5.2m5.0m4.0m4.0m3.5m282.0k

Current Assets

17.1m21.5m18.4m15.7m14.3m10.7m15.1m12.2m10.9m10.6m10.3m10.3m10.4m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(8.6m)(14.9m)(18.6m)(29.1m)

Depreciation and Amortization

993.0k1.4m1.2m830.0k

Inventories

(1.3m)416.0k375.0k615.0k

Accounts Payable

(295.0k)1.4m(2.4m)(1.1m)
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(3.3m)(4.4m)(4.8m)(3.4m)(4.0m)(10.9m)(22.4m)(3.4m)(2.1m)(3.4m)(30.5m)

Depreciation and Amortization

587.0k659.0k261.0k159.0k333.0k

Inventories

(430.0k)5.9m5.2m5.0m4.0m568.0k3.5m258.0k(224.0k)(358.0k)

Accounts Payable

(397.0k)3.0m3.2m4.7m5.7m(626.0k)3.3m(832.0k)2.1m1.9m69.0k(242.0k)
USDY, 2018

Financial Leverage

2.6 x
Show all financial metrics

Cesca Therapeutics Operating Metrics

FY, 2016

Patents Issued

25
Show all operating metrics
Report incorrect company information

Cesca Therapeutics Online and Social Media Presence

Embed Graph
Report incorrect company information

Cesca Therapeutics News and Updates

Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP® II AutoXpress® Platform for Clinical Cord Blood Banking

RANCHO CORDOVA, Calif., Nov. 19, 2018 /PRNewswire/ -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that its device subsidiary, ThermoGenesis® Corp., has received 510(k) clearance...

Cesca Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Conference Call to be Held at 4:30 p.m. ET (1:30 p.m. PT) Conference Call to be Held at 4:30 p.m. ET (1:30 p.m. PT)
Report incorrect company information

Cesca Therapeutics Company Life and Culture

Report incorrect company information

Cesca Therapeutics Frequently Asked Questions

  • When was Cesca Therapeutics founded?

    Cesca Therapeutics was founded in 1986.

  • How many employees does Cesca Therapeutics have?

    Cesca Therapeutics has 95 employees.

  • What is Cesca Therapeutics revenue?

    Latest Cesca Therapeutics annual revenue is $14.5 m.

  • What is Cesca Therapeutics revenue per employee?

    Latest Cesca Therapeutics revenue per employee is $152.9 k.

  • Who are Cesca Therapeutics competitors?

    Competitors of Cesca Therapeutics include Kiniksa Pharmaceuticals, Sartorius Stedim BioOutsource and Neurosearch.

  • Where is Cesca Therapeutics headquarters?

    Cesca Therapeutics headquarters is located at 2711 Citrus Rd, Rancho Cordova.

  • Where are Cesca Therapeutics offices?

    Cesca Therapeutics has offices in Rancho Cordova, Gurgaon and Wuxi Shi.

  • How many offices does Cesca Therapeutics have?

    Cesca Therapeutics has 3 offices.